 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Metacrine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapies for patients with liver and gastrointestinal (GI) diseases. It offers farnesoid X receptor (FXR), which is central to modulating liver and GI diseases. The company was founded by Ronald M. Evans, Richard A. Heyman, and Michael Downes in 2014 and is headquartered in San Diego, CA.

Current Price	$0.545
Prev Close	$0.554
Open	$0.5363
Dividend Yield	N/A
50-Day Moving Average	$0.5612
Beta	0.78
Avg. Volume	48,854.36
PE Ratio	-0.53

52-Week High	$0.58
52-Week Low	$0.303
Market Capitalization	$23.2M
EPS	-$1.02
Price to Book	0.63
Revenue Per Employee	N/A
Enterprise Value/EBITDA	0.51

MTCR Metacrine Inc

About

Feed

Fundamentals

News